Drug Executive Collapses During Oval Office Press Conference
During a Thursday press conference in the Oval Office, a drug executive fainted as President Donald Trump announced a deal with pharmaceutical companies to lower obesity drug prices.
Incident Details
The press event, held to discuss an agreement with Eli Lilly and Novo Nordisk, was abruptly interrupted when Gordon Findlay, Novo Nordisk's global brand director, collapsed. The deal aimed to expand coverage and reduce costs for popular obesity treatments Zepbound and Wegovy.
Immediate Response
Eli Lilly's CEO, David Ricks, noticed the collapse and asked,
“Are you OK? Gordon, are you OK?”Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, immediately assisted as Findlay fell to his knees and lost consciousness.
Press Conference Conclusion
Following the incident, the press was promptly escorted out of the room. Health and Human Services Secretary was also present during the event.
Getty Images identified the man who fainted as Gordon Findlay, the global brand director for Novo Nordisk.
Summary: An Oval Office press conference was cut short after Gordon Findlay, a drug executive, collapsed while President Trump unveiled a deal to reduce obesity drug costs, with quick aid from Dr. Mehmet Oz.
Would you like the summary sentence to be more formal or conversational?